Tianjin Tianyao Pharmaceuticals Co Ltd Net Asset Quality Index

Latest as of September 2025: 67.8%

Tianjin Tianyao Pharmaceuticals Co Ltd net asset quality index. Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Net Asset Quality Index of 67.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.74 Billion minus total liabilities of CN¥1.85 Billion yields net assets of CN¥3.89 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 600488 net assets for net asset value and shareholders' equity analysis.

Quality Index

67.8%
Equity / Total Assets

Net Assets

CN¥3.89 Billion
CNY

Total Assets

CN¥5.74 Billion
CNY

Total Liabilities

CN¥1.85 Billion
CNY

Net Asset Quality Index of Tianjin Tianyao Pharmaceuticals Co Ltd (1998–2024)

Net asset quality index of Tianjin Tianyao Pharmaceuticals Co Ltd from 1998 to 2024. This chart shows how Tianjin Tianyao Pharmaceuticals Co Ltd's Net Asset Quality Index has evolved across 27 annual periods from 1998 to 2024. As of September 2025, the index stands at 67.8%, representing net assets of CN¥3.89 Billion against total assets of CN¥5.74 Billion CNY. Check Tianjin Tianyao Pharmaceuticals Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Tianjin Tianyao Pharmaceuticals Co Ltd Net Asset Quality Index by Year (1998–2024)

Tianjin Tianyao Pharmaceuticals Co Ltd net asset quality index by year from 1998 to 2024. The table below presents the year-by-year Net Asset Quality Index for Tianjin Tianyao Pharmaceuticals Co Ltd from 1998 to 2024, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Tianjin Tianyao Pharmaceuticals Co Ltd market capitalisation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2024 68.2% CN¥3.89 Billion CN¥5.70 Billion CN¥1.81 Billion ▲ +7.1 pp
2023 61.1% CN¥3.75 Billion CN¥6.14 Billion CN¥2.39 Billion ▲ +4.7 pp
2022 56.4% CN¥3.75 Billion CN¥6.65 Billion CN¥2.90 Billion ▼ -3.7 pp
2021 60.2% CN¥3.82 Billion CN¥6.35 Billion CN¥2.53 Billion ▼ -0.9 pp
2020 61.1% CN¥3.77 Billion CN¥6.18 Billion CN¥2.40 Billion ▼ -6.8 pp
2019 67.9% CN¥3.59 Billion CN¥5.28 Billion CN¥1.70 Billion ▼ -0.5 pp
2018 68.4% CN¥3.28 Billion CN¥4.80 Billion CN¥1.52 Billion ▼ -4.7 pp
2017 73.1% CN¥3.13 Billion CN¥4.28 Billion CN¥1.15 Billion ▼ -9.9 pp
2016 83.0% CN¥2.49 Billion CN¥3.00 Billion CN¥511.21 Million ▲ +2.2 pp
2015 80.7% CN¥2.45 Billion CN¥3.03 Billion CN¥584.42 Million ▼ -2.0 pp
2014 82.7% CN¥2.40 Billion CN¥2.90 Billion CN¥501.34 Million ▲ +7.9 pp
2013 74.8% CN¥2.33 Billion CN¥3.11 Billion CN¥785.64 Million ▲ +3.8 pp
2012 70.9% CN¥1.77 Billion CN¥2.49 Billion CN¥724.13 Million ▲ +1.1 pp
2011 69.8% CN¥1.69 Billion CN¥2.42 Billion CN¥729.86 Million ▲ +13.9 pp
2010 55.9% CN¥1.63 Billion CN¥2.92 Billion CN¥1.29 Billion ▼ -3.4 pp
2009 59.3% CN¥1.56 Billion CN¥2.62 Billion CN¥1.07 Billion ▲ +0.8 pp
2008 58.5% CN¥1.50 Billion CN¥2.57 Billion CN¥1.07 Billion ▼ -4.6 pp
2007 63.1% CN¥1.46 Billion CN¥2.32 Billion CN¥854.65 Million ▲ +18.7 pp
2006 44.4% CN¥1.08 Billion CN¥2.43 Billion CN¥1.35 Billion ▼ -8.4 pp
2005 52.8% CN¥1.04 Billion CN¥1.98 Billion CN¥933.43 Million ▼ -11.8 pp
2004 64.6% CN¥987.47 Million CN¥1.53 Billion CN¥541.10 Million ▲ +6.3 pp
2003 58.3% CN¥935.65 Million CN¥1.60 Billion CN¥669.25 Million ▲ +3.0 pp
2002 55.3% CN¥784.51 Million CN¥1.42 Billion CN¥634.50 Million ▼ -7.7 pp
2001 63.0% CN¥714.63 Million CN¥1.13 Billion CN¥419.39 Million ▲ +20.9 pp
2000 42.1% CN¥211.75 Million CN¥502.78 Million CN¥291.03 Million ▲ +6.5 pp
1999 35.6% CN¥146.16 Million CN¥410.77 Million CN¥264.61 Million ▲ +7.0 pp
1998 28.6% CN¥83.00 Million CN¥289.93 Million CN¥206.93 Million —
pp = percentage points